Moreover, IL-1β promotes hepatic stellate cells (HSCs) activation, resulting in liver fibrosis, as well as enhances the accumulation of triglyceride and hepatocyte injury contributing to liver steatosis (Miura et al., 2010; Petrasek et al., 2011). The gene discussed is IL1B; the disease is fatty liver disease.